AI-Powered Biomarker Discovery for Disease Diagnosis and Prognosis

Abstract

Artificial intelligence (AI) is now a revolutionary force behind biomarker discovery, disease diagnosis, and personalized medicine. The latest advances are powered by AI-enabled tools like machine learning, deep learning, and multi-omics integration to accelerate the discovery of predictive and prognostic biomarkers in different diseases including cancer, cardiovascular diseases, and neurodegenerative diseases. AI makes possible the examination of genomic, proteomic, and clinical large-scale data to facilitate the design of personalized therapy, prediction of diseases early on, and the optimization of therapeutic intervention. Analytical platforms such as deep neural networks, graph-based learning, and AI-driven sensors enhance the sensitivity and specificity of detection of biomarkers, while AI-driven predictive modeling makes prognosis evaluation and drug repurposing possible. Multidisciplinary approaches combining clinical mass spectrometry, bioinformatics, and big data analytics improve patient stratification and diagnostic accuracy even further. Especially, AI application in oncology, autoimmune diseases, and Alzheimer's disease showcases its potential in the future to revolutionize patient care with rapid, reliable, and personalized insights. Notwithstanding the challenges of model explainability and data heterogeneity, AI-driven biomarker identification is an important step towards precision medicine, laying a bridge between computational analysis and medical practice. Subsequent research would seek to integrate AI frameworks into routine diagnostics with the aim of facilitating real-time, scalable, and ethically responsible healthcare solutions.

Ähnliche Arbeiten